<sup>64</sup> CuCl <sub>2</sub> produced by direct neutron activation route as a cost-effective probe for cancer imaging: the journey has begun
Rubel Chakravarty(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Priyalata Shetty(Bhabha Atomic Research Centre), K.V. Vimalnath(Bhabha Atomic Research Centre), Sudipta Chakraborty, P. A. Hassan(University of Delaware)
Cited by 17
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Microstructural Changes in SDS Micelles Induced by Hydrotropic Salt
|Langmuir|2002|276
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117